We are live on ! Find out more
TNGX icon

Tango Therapeutics
TNGX

100 hedge funds and large institutions have $1,000M invested in Tango Therapeutics in 2023 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 33 increasing their positions, 26 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

341% more capital invested

Capital invested by funds: $227M → $1,000M (+$773M)

200% more funds holding in top 10

Funds holding in top 10: 2 → 6 (+4)

100% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 11

27% more repeat investments, than reductions

Existing positions increased: 33 | Existing positions reduced: 26

12% more funds holding

Funds holding: 89 → 100 (+11)

10.02% more ownership

Funds ownership: 77.28% → 87.3% (+10%)

Holders
100
Holders Change
+11
Holders Change %
+12.36%
% of All Funds
1.59%
Holding in Top 10
6
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+200%
% of All Funds
0.1%
New
22
Increased
33
Reduced
26
Closed
11
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
NI
Nextech Invest
Switzerland
+$33.7M
2
EC
EcoR1 Capital
California
+$28.5M
3
PA
Perceptive Advisors
New York
+$14.8M
4
Fidelity Investments
Fidelity Investments
Massachusetts
+$7.79M
5
BCLSI
Bain Capital Life Sciences Investors
Massachusetts
+$5.92M

Top Sellers

Rank Fund Capital Flow
1
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
-$1.07M
2
Millennium Management
Millennium Management
New York
-$1.03M
3
Citadel Advisors
Citadel Advisors
Florida
-$548K
4
BlackRock
BlackRock
New York
-$396K
5
Man Group
Man Group
United Kingdom
-$277K
Name Holding Trade Value Shares
Change 		Change in
Stake
TGI
1
TRV GP IV
Massachusetts
$218M – – –
Fidelity Investments
2
Fidelity Investments
Massachusetts
$131M +$7.79M +1,276,945 +12%
EC
3
EcoR1 Capital
California
$98.2M +$28.5M +4,674,522 +116%
BC
4
Boxer Capital
California
$80.2M – – –
NI
5
Nextech Invest
Switzerland
$62.3M +$33.7M +5,533,980 New
SCA
6
Southpoint Capital Advisors
New York
$59.4M +$4.74M +776,699 +17%
BlackRock
7
BlackRock
New York
$40.1M -$396K -64,957 -2%
Vanguard Group
8
Vanguard Group
Pennsylvania
$33.1M +$1.21M +197,624 +7%
BCLSI
9
Bain Capital Life Sciences Investors
Massachusetts
$32.6M +$5.92M +970,873 +51%
PA
10
Perceptive Advisors
New York
$27.2M +$14.8M +2,418,968 New
ACA
11
Avoro Capital Advisors
New York
$25M +$3.55M +582,222 +36%
SCM
12
Soleus Capital Management
Connecticut
$21.7M +$928K +152,122 +9%
Adage Capital Partners
13
Adage Capital Partners
Massachusetts
$19.8M +$3.45M +564,971 +47%
CC
14
Casdin Capital
New York
$14.7M +$1.87M +307,349 +31%
Geode Capital Management
15
Geode Capital Management
Massachusetts
$11.7M +$586K +96,157 +10%
State Street
16
State Street
Massachusetts
$10.7M +$335K +54,940 +6%
Balyasny Asset Management
17
Balyasny Asset Management
Illinois
$9.51M +$5.15M +844,377 New
DM
18
Deerfield Management
New York
$8.94M +$4.84M +793,729 New
Invesco
19
Invesco
Georgia
$8.72M +$4.58M +751,593 +3,247%
BBA
20
Baker Bros. Advisors
New York
$8.45M – – –
Bessemer Group
21
Bessemer Group
New Jersey
$7.98M – – –
HMC
22
Harvard Management Company
Massachusetts
$7.98M – – –
SB
23
Samsara BioCapital
California
$7.09M – – –
Ensign Peak Advisors
24
Ensign Peak Advisors
Utah
$5.58M – – –
Northern Trust
25
Northern Trust
Illinois
$4.52M +$91.1K +14,945 +4%
1
2 3 4 5

TNGX Hedge Fund Activity: Q3 2023 in Review

100 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Tango Therapeutics (TNGX) for Q3 2023, worth a combined $1,000M — up 341% from $227M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new TNGX positions and 11 closed out — a net gain of 11 holders — while 33 added to existing stakes and 26 trimmed.

The largest buyer was Nextech Invest, opening a new position worth an estimated $33.7M. The largest seller was Jacobs Levy Equity Management, cutting an estimated $1.07M.

  • 100 institutional investors held Tango Therapeutics (TNGX) as of Q3 2023, up from 89 in Q2 2023.
  • Funds reported $1,000M of Tango Therapeutics stock for Q3 2023, up 341% quarter-over-quarter.
  • 22 funds opened new Tango Therapeutics positions in Q3 2023 and 11 closed out, a net change of +11 holders.
  • The largest Tango Therapeutics buyer in Q3 2023 was Nextech Invest, an estimated $33.7M added.
  • The largest Tango Therapeutics seller in Q3 2023 was Jacobs Levy Equity Management, an estimated $1.07M sold.

Based on aggregated 13F filings for Q3 2023.